Hormonal
Once-weekly subcutaneous semaglutide at 2.4 mg is effective and safe for weight loss in non-diabetic adults and adolescents with overweight or obesity, demonstrating superiority over both placebo and daily liraglutide.
For non-diabetic adults and adolescents with obesity, once-weekly subcutaneous semaglutide (2.4 mg) combined with lifestyle changes is a highly effective treatment for significant weight loss. It is superior to placebo and daily liraglutide. While gastrointestinal side effects like nausea are common, they often subside over time. This treatment is FDA-approved and supported by robust clinical trials.
Os artigos expostos neste estudo serviram para consolidar a segurança e eficácia do uso de semaglutida subcutânea na dose de 2,4 mg em pacientes não diabéticos, com o intuito de promover o emagrecimento e diminuição do risco cardiometabólico. Essa medicação se mostrou superior a placebo e a outro agonista de GLP-1, a liragutida.
Why this rating
The paper synthesizes multiple high-quality Randomized Clinical Trials (RCTs) including STEP 1, 3, 4, 5, 8, and STEP TEENS, published in major journals (NEJM, JAMA, Nature Medicine).
Source
Semaglutida no tratamento de obesidade e sobrepeso
Izadora Pires de Oliveira et al. · Research Society and Development · 2023
DOI 10.33448/rsd-v12i3.40656
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →